![]() |
市場調查報告書
商品編碼
2032562
筆式注射針市場報告:按類型、針頭長度、治療方法、購買方式、最終用戶和地區分類(2026-2034 年)Pen Needles Market Report by Type, Needle Length, Therapy, Mode of Purchase, End User, and Region 2026-2034 |
||||||
2025年,全球胰島素筆針市場規模達47億美元。展望未來,IMARC Group預測,到2034年,該市場規模將達到131億美元,2026年至2034年的複合年成長率為11.67% 。成長要素包括糖尿病和慢性病盛行率上升、老年人口增加、醫療保健領域投資增加、技術快速進步、胰島素自我注射增加以及優惠的報銷政策訂定。
糖尿病和其他慢性疾病的盛行率增加
全球糖尿病和其他慢性疾病盛行率的不斷上升是胰島素筆針市場成長的主要驅動力。根據國際糖尿病聯盟(IDF)發布的《糖尿病地圖集》,2021年,20至79歲成年人中,10.5%患有糖尿病,其中超過一半的人並不知道自己已被確診。據預測,到2045年,每八名成年人中就有一人(約7.83億人)將患有糖尿病,增幅約46%。因此,糖尿病的管理需要頻繁監測和注射胰島素,而胰島素筆針正是透過配備筆針的胰島素筆來實現的。由於便捷易用,胰島素筆針是需要頻繁注射胰島素的糖尿病患者不可或缺的工具。
老年人口的成長
注射筆市場的預測顯示,老年人口的成長是市場成長的關鍵促進因素。由於與老齡化相關的生理變化和較高的合併症盛行率,老年人更容易患有包括糖尿病在內的慢性疾病。世界衛生組織(WHO)預測,全球60歲及以上人口的比例將從2015年的12%增加到2050年的22%,幾乎翻倍。這種人口結構的變化將對醫療保健系統和醫療設備的需求產生重大影響。此外,具有易用性、減輕疼痛和安全機制等特點的注射筆對老年人群尤其有益。隨著老年人口的持續成長,針對老年人特定需求的產品需求預計將會增加,從而推動市場擴張。
擴大對醫療領域的投資
許多國家加大對醫療產業的投資,正在提升胰島素筆針的市場佔有率。例如,2022年歐洲各國政府醫療保健總支出達1.221兆歐元,佔GDP的7.7%。同樣,印度的公共醫療保健支出在2022年佔GDP的2.2%,2023年佔2.1%。這種成長促進了糖尿病等疾病的診斷、監測和管理,從而推高了對胰島素筆針的需求。此外,成本效益高的保險覆蓋範圍和報銷方案的製定,也鼓勵患者將胰島素筆和筆針作為治療選擇。例如,在美國,2022年有3.04億人(佔總人口的92.1%)享有醫療保險,也促進了胰島素筆針的需求成長。
The global pen needles market size reached USD 4.7 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.1 Billion by 2034, exhibiting a growth rate (CAGR) of 11.67% during 2026-2034. The market is driven by the rising prevalence of diabetes and chronic diseases, expanding geriatric population, increasing investment in the healthcare sector, rapid technological advancements, growing self-administration of insulin, and the imposition of favorable reimbursement policies.
Increasing Prevalence of Diabetes and Other Chronic Diseases
The rising prevalence of diabetes and other chronic diseases across the globe is a major factor driving the pen needles market growth. According to the International Diabetes Federation's (IDF) Diabetes Atlas, 10.5% of the adult population aged 20 to 79 had diabetes in 2021, with over half unaware of the diagnosis. By 2045, this forecast predicts that one in every eight adults, or nearly 783 million, will have diabetes, which is an approximately 46% rise. In line with this, diabetes management necessitates frequent monitoring and insulin administration, which is accomplished with insulin pens equipped with pen needles. Pen needles are an indispensable tool for diabetes patients who require frequent insulin injections due to their ease and user-friendliness.
Expanding Geriatric Population
The pen needles market forecast highlights that the expanding geriatric population is a significant factor that is resulting in the growth of this market. Geriatric adults are more susceptible to chronic diseases, including diabetes, due to age-related physiological changes and a higher prevalence of comorbidities. According to the World Health Organization (WHO), the proportion of the world's population over 60 years is projected to nearly double from 12% in 2015 to 22% by 2050. This demographic shift has profound implications for healthcare systems and the demand for medical devices. Additionally, pen needles that are designed with features like easy handling, minimal pain, and safety mechanisms are beneficial for this age group. As the geriatric population continues to grow, the demand for products that are tailored to their specific needs is expected to increase, driving the expansion of the market.
Growing Investment in the Healthcare Sector
The increasing funding in the healthcare industry by several countries is strengthening the pen needle market share. For example, in 2022, Europe's overall government spending on health totaled €1221 Billion, or 7.7% of GDP. Similarly, India's public healthcare spending accounted for 2.1% of GDP in FY23 and 2.2% in FY22. This expansion has been allowing for improved diagnosis, monitoring, and management of illnesses such as diabetes, which drives up the demand for pen needles. Furthermore, the availability of cost-effective insurance coverage and reimbursement schemes have been encouraging patients to explore the use of insulin pens and pen needles as a treatment option. For instance, 92.1 percent of people, or 304.0 million in the U.S., had health insurance at some point during 2022, which also increased the pen needles demand.
Standard pen needles accounts for the majority of the market share
As per the pen needles market outlook and analysis, the standard pen needles segment represented the largest share, driven by their widespread usage and acceptance among patients and healthcare providers. These needles are designed to fit most insulin pens and are known for their versatility, ease of use, and availability in various lengths and gauges. Moreover, standard pen needles are preferred due to their cost-effectiveness and the broad range of options that ensure compatibility with various insulin delivery systems. Besides this, the continuous improvements in design and technology, which enhance comfort and reduce pain during injections, are positively impacting the pen needle market value.
8mm holds the largest share of the industry
Based on the pen needles market report and trends, the 8mm needle length segment holds the largest share in the market, attributed to its balanced efficacy and comfort for a wide range of patients. This length is considered optimal for subcutaneous insulin delivery, ensuring adequate penetration to the subcutaneous tissue while minimizing the risk of intramuscular injection. Moreover, the 8mm needles are widely recommended by healthcare providers due to their versatility, making them suitable for adults and children. Along with this, the extensive use of 8mm needles in clinical practice, coupled with patient familiarity and acceptance, is enhancing the pen needles market size.
Insulin represents the leading market segment
According to the pen needles market overview and segmentation, insulin therapy constituted the largest share, driven by the growing prevalence of diabetes and the necessity of insulin administration for effective disease management. In line with this, insulin therapy requires frequent and precise injections, making pen needles an essential tool for diabetic patients. Moreover, the rising convenience, accuracy, and reduced pain associated with pen needles that enhance patient compliance and quality of life are contributing to the market growth. Additionally, the development of advanced insulin pens and continuous innovations in product technology are supporting the pen needle market price trends.
Retail exhibits a clear dominance in the market
As per the pen needles market research report, the retail segment represented the largest share, driven by the convenience and accessibility it offers to consumers. Retail pharmacies and online stores provide an easy and immediate access point for patients as they offer quick supplies without the need for a medical facility visit. Besides this, the broad distribution networks of retail channels ensure widespread availability, catering to urban and rural populations. Additionally, retail outlets offer a variety of brands and products, allowing patients to choose pen needles that best meet their needs and preferences.
Hospitals and clinics dominate the market
Hospitals and clinics constituted the largest segment, driven by the high volume of medical procedures and chronic disease management performed in these settings. They are primary healthcare providers where a significant number of diabetes patients receive their diagnosis, treatment plans, and ongoing management, necessitating a steady supply of pen needles for insulin administration and other injectable therapies. Moreover, these healthcare facilities prioritize patient safety and efficacy, opting for high-quality needles to ensure precise and comfortable medication delivery. Additionally, hospitals and clinics serve as the first point of education for patients on the correct use of these needles, boosting the market growth.
Europe leads the market, accounting for the largest pen needles market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, Europe represents the largest regional market for pen needles.
Europe holds the largest segment in the pen needles industry, driven by a combination of high diabetes prevalence, advanced healthcare infrastructure, and supportive government policies. In line with this, the robust healthcare systems that provide extensive access to diabetes management tools, coupled with increased support from strong reimbursement frameworks that reduce the financial burden on patients, are boosting the market growth. Along with this, the high awareness of diabetes care, with proactive public health campaigns and educational programs that promote the use of these pens, is favoring the market growth. Additionally, the presence of several leading medical device manufacturers that foster innovation and boost the availability of advanced needle technologies is stimulating the pen needle market revenue.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the pen needles industry include:
The major pen needle companies are focusing on innovation, strategic partnerships, and expanding their global footprint to maintain and enhance their market positions. They are focusing on innovating with ultra-fine and shorter needles to improve patient comfort and compliance. Moreover, some players are leveraging their strong presence in the insulin delivery market to integrate advanced pen needles with their insulin pens to ensure seamless and effective diabetes management. Besides this, they are working on expanding their product portfolio with technologically advanced solutions and enhancing distribution networks to reach a broader audience. Moreover, these companies are actively involved in strategic collaborations and acquisitions to strengthen their market presence and capabilities.